Huakang Biomedical Holdings Company Limited
Huakang Biomedical Holdings Company Limited (8622.HK) Company Profile & Overview
Explore Huakang Biomedical Holdings Company Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Huakang Biomedical Holdings Company Limited (8622.HK) Company Profile & Overview
Huakang Biomedical Holdings Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of in-vitro diagnostic (IVD) reagents in the People's Republic of China. It offers male and female fertility IVD, parasite antibody detection, and Epstein-Barr virus antibody detection reagents; auxiliary reproductive supplies and equipment; and healthcare products and supplements under the Nutronic brand to customers, as well as through online and offline platforms and channels. The company sells its products directly to hospitals and medical institutions, as well as to distributors. Huakang Biomedical Holdings Company Limited was founded in 1992 and is headquartered in Wan Chai, Hong Kong.